CLINICAL_TRIALS
trial_result
· 2026-04-02
Clinical Trial Update: CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease [Phase 1]
Summary
This clinical trial update reports completion of a Phase 1 study evaluating CD40-L blockade to prevent acute graft-versus-host disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Graft-versus-host-disease, GVHD | Phase 1 | Status: COMPLETED